rare disease research hub

BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance

This study looks at whether a drug called Adcetris can help people with a rare skin cancer (cutaneous T-cell lymphoma) stay cancer-free after a stem cell transplant. We want to see if it prevents the cancer from coming back.